Search

Your search keyword '"Shibamiya, Aya"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Shibamiya, Aya" Remove constraint Author: "Shibamiya, Aya"
40 results on '"Shibamiya, Aya"'

Search Results

1. Physioxia rewires mitochondrial complex composition to protect stem cell viability

3. Immature human engineered heart tissues engraft in a guinea pig chronic injury model

4. Functional characterisation of a patient-derived laminopathy model in human engineered heart tissues recapitulates fibrosis and mechanical decoupling defect

6. Transplanted iPSC-derived cardiomyocytes actively contribute to left ventricular function

7. Contractile Force of Transplanted Cardiomyocytes Actively Supports Heart Function After Injury

9. Immature human engineered heart tissues engraft in a guinea pig chronic injury model

10. Author Correction: Differentiation of cardiomyocytes and generation of human engineered heart tissue

11. A potential future Fontan modification: preliminary in vitro data of a pressure-generating tube from engineered heart tissue

12. Comparison of Human Induced Pluripotent Stem Cells Cultured at Different Oxygen Concentrations by Proteomic Analysis Suggests Normoxia-induced Cellular Senescence

14. Contractile force of transplanted cardiomyocytes contributes to heart function after injury

15. Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy

17. potential future Fontan modification: preliminary in vitro data of a pressure-generating tube from engineered heart tissue.

19. Human Engineered Heart Tissue Patches Remuscularize the Injured Heart in a Dose-Dependent Manner

20. Cell Banking of hiPSCs: A Practical Guide to Cryopreservation and Quality Control in Basic Research

22. Additional file 1: of Clonal dynamics studied in cultured induced pluripotent stem cells reveal major growth imbalances within a few weeks

23. Evaluation of MYBPC3 trans -Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes

24. Differentiation of cardiomyocytes and generation of human engineered heart tissue

38. Non-viral in vivo thrombomodulin gene transfer prevents early loss of thromboresistance of grafted veins

39. Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes.

40. 1,25(OH)(2)D(3) blocks TNF-induced monocytic tissue factor expression by inhibition of transcription factors AP-1 and NF-kappaB.

Catalog

Books, media, physical & digital resources